Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 5
1951 6
1952 3
1953 3
1954 5
1955 4
1956 4
1957 3
1958 1
1959 5
1960 6
1961 2
1962 3
1963 6
1964 9
1965 3
1985 5
1986 12
1987 13
1988 50
1989 104
1990 183
1991 152
1992 242
1993 247
1994 325
1995 356
1996 391
1997 358
1998 371
1999 391
2000 399
2001 363
2002 399
2003 408
2004 421
2005 468
2006 506
2007 462
2008 535
2009 526
2010 595
2011 646
2012 659
2013 634
2014 685
2015 687
2016 641
2017 709
2018 767
2019 773
2020 881
2021 890
2022 849
2023 839
2024 884
2025 1037
2026 156

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,446 results

Results by year

Filters applied: . Clear all
Page 1
Candida albicans targets that potentially synergize with fluconazole.
Lu H, Shrivastava M, Whiteway M, Jiang Y. Lu H, et al. Crit Rev Microbiol. 2021 May;47(3):323-337. doi: 10.1080/1040841X.2021.1884641. Epub 2021 Feb 15. Crit Rev Microbiol. 2021. PMID: 33587857 Review.
However, fluconazole has only a fungistatic activity in C. albicans, therefore, in the long-term treatment of C. albicans infection with fluconazole, C. albicans has the potential to acquire fluconazole resistance. A promising approach to increase fluconaz …
However, fluconazole has only a fungistatic activity in C. albicans, therefore, in the long-term treatment of C. albicans infection w …
Fluconazole.
Hay RJ. Hay RJ. J Infect. 1990 Jul;21(1):1-6. doi: 10.1016/0163-4453(90)90508-6. J Infect. 1990. PMID: 2384673 No abstract available.
Fluconazole.
Jura SE, Hillenbrand K. Jura SE, et al. Pediatr Rev. 2006 Apr;27(4):158-9. doi: 10.1542/pir.27-4-158. Pediatr Rev. 2006. PMID: 16581959 No abstract available.
Fluconazole: pharmacokinetics and indications.
Montero-Gei F. Montero-Gei F. Arch Med Res. 1993 Winter;24(4):377-85. Arch Med Res. 1993. PMID: 8118162 Review.
Fluconazole is a new systemic azole antifungal agent, with the imidazole group substituted by a triazole, presenting a decrease in lipophilicity, soluble in water, weakly bound to plasma proteins, and a wide range of formulations. The time to reach steady-state with a once …
Fluconazole is a new systemic azole antifungal agent, with the imidazole group substituted by a triazole, presenting a decrease in li …
Clinical pharmacokinetics of fluconazole.
Debruyne D, Ryckelynck JP. Debruyne D, et al. Clin Pharmacokinet. 1993 Jan;24(1):10-27. doi: 10.2165/00003088-199324010-00002. Clin Pharmacokinet. 1993. PMID: 8448970 Review.
Fluconazole was recently developed for the treatment of superficial and systemic fungal infections. ...Neither old age nor irradiation affect fluconazole pharmacokinetics, but the t1/2 was shorter in children.(ABSTRACT TRUNCATED AT 400 WORDS)...
Fluconazole was recently developed for the treatment of superficial and systemic fungal infections. ...Neither old age nor irradiatio …
Fluconazole.
Farrington E. Farrington E. Pediatr Nurs. 1990 Jul-Aug;16(4):376-7. Pediatr Nurs. 1990. PMID: 2392348 No abstract available.
Fluconazole.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1990 May 18;32(818):50-2. Med Lett Drugs Ther. 1990. PMID: 2185400 Clinical Trial. No abstract available.
Fluconazole.
Lubowski T. Lubowski T. Conn Med. 1990 Aug;54(8):449-51. Conn Med. 1990. PMID: 2225810 No abstract available.
Fluconazole: a new antifungal agent.
Kowalsky SF, Dixon DM. Kowalsky SF, et al. Clin Pharm. 1991 Mar;10(3):179-94. Clin Pharm. 1991. PMID: 2040125 Review.
Fluconazole's activity in vitro does not reflect its effectiveness in vivo. Pharmacokinetic characteristics include water solubility and excellent bioavailability, low protein binding, extensive tissue distribution, and penetration into the cerebrospinal fluid. ...T …
Fluconazole's activity in vitro does not reflect its effectiveness in vivo. Pharmacokinetic characteristics include water solu …
Fluconazole use during breastfeeding.
Kaplan YC, Koren G, Ito S, Bozzo P. Kaplan YC, et al. Can Fam Physician. 2015 Oct;61(10):875-6. Can Fam Physician. 2015. PMID: 26759844 Free PMC article.
ANSWER: Available data regarding fluconazole use during breastfeeding are reassuring. Fluconazole is also used in the treatment of fungal diseases in infants and has a good safety profile. Therefore, there is no need to interrupt breastfeeding when a mother is treat …
ANSWER: Available data regarding fluconazole use during breastfeeding are reassuring. Fluconazole is also used in the treatmen …
18,446 results
You have reached the last available page of results. Please see the User Guide for more information.